Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-24
2011-11-29
Solola, Taofiq A (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S464000
Reexamination Certificate
active
08067463
ABSTRACT:
The present invention provides a compound having the structure (I) and processes for the production thereof and the intermediates used in such process.
REFERENCES:
patent: 1 265 073 (2002-12-01), None
patent: WO 99/67254 (1999-12-01), None
patent: WO 99/67417 (1999-12-01), None
patent: WO 01/24240 (2001-04-01), None
patent: WO 01/25240 (2001-04-01), None
patent: WO 02/081478 (2002-10-01), None
patent: WO 02/083657 (2002-10-01), None
patent: WO 02/092595 (2002-11-01), None
patent: WO 03/049746 (2003-06-01), None
patent: WO 03/053435 (2003-07-01), None
patent: WO 03/057173 (2003-07-01), None
patent: WO 03/064406 (2003-08-01), None
patent: WO 03/070976 (2003-08-01), None
patent: WO 03/076413 (2003-09-01), None
patent: WO 03/078438 (2003-09-01), None
patent: WO 03/090690 (2003-11-01), None
patent: WO 03/090691 (2003-11-01), None
patent: WO 03/097616 (2003-11-01), None
patent: WO 03/106461 (2003-12-01), None
patent: WO 2004/003817 (2004-01-01), None
Ohtaka, H. et al., “Overcoming drug resistance in HIV-1 chemotherapy: The binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug resistant mutants of the HIV-1 protease”, Protein Science (2002), vol. 11, pp. 1908-1916.
Gatanaga, H. et al., “Amino Acid Substitutions in Gag Protein at Non-cleavage Sites Are Indispensable for the Development of a High Multitude of HIV-1 Resistance against Protease Inhibitors”, Journal of Biological Chemistry, (2002), vol. 277, No. 8, pp. 5952-5961.
Ghosh, A. et al, “Antiviral activity of UIC-PI, a novel inhibitor of the human immunodeficiency virus type 1 protease”, Antiviral Research, (2002), vol. 54, No. 1, pp. 29-36.
Yoshimura, K. et al., “A Potent Human Immunodeficjency Virus Type 1 Protease Inhibitor, UIC-94003 (TMC-126), and Selection of a Novel (A28S) Mutation in the Protease Active Site”, Journal of Virology, (2002), vol. 76, No. 3, pp. 1349-1358.
Ghosh, A., et al., “Structure-based design of non-peptide HIV protease ihhibitors”, IL Farmaco, (2001), vol. 56, Nos. 1-2, pp. 29-32.
Ghosh, A., et al., “Potent HIV Protease Inhibitors Incorporating High-Affinity P2- Ligands and (R)-(Hydroyxethylamino)Sulfonamide Isostere”, Bioorganic & Medicinal Chemistry Letters, (1998), vol. 8, No. 6, pp. 687-690.
Ghosh, A., et al., “Nonpeptidal P2Ligands for HIV Protease Inhibitors: Structure-Based Design, Synthesis, and Biological Evaluation”, Journal of Medicinal Chemistry, (1996), vol. 39, pp. 3278-3290.
Koh, Y., et al., “Novelbis-Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human Immunodeficiency Virus In Vitro”, Antimicrobial Agents and Chemotherapy, (2003), vol. 47, No. 10, pp. 3123-3129.
Trost, B.M. et al., “Comprehensive Organic Synthesis”, Pergamon Press, (1991), vol. 7, pp. 291-303.
Tidwell, T.T., “Oxidation of Alcohols by Activated Dimethyl Sulfoxide and Related Reactions: An Update”, Synthesis, (1990), vol. 1990, No. 10, pp. 857-870.
Tidwell, T.T., “Oxidation of Alcohols to Carbonyl Compounds Via Alkoxysulfonium Ylides: The Moffatt, Swern, and Related Oxidations”, Organic Reactions, (1990), vol. 39, pp. 297-557.
Parikh, J.R., et al., “Sulfur Trioxide in the Oxidation of Alcohols by Dimethyl Sulfoxide”, Journal of the American Chemical Society, (1967), vol. 89, No. 21, pp. 5505-5507.
Mancuso, A.J., et al., “Activated Dimethyl Sulfoxide: Useful Reagents for Synthesis”, Synthesis, (1981), vol. 1981, No. 3, pp. 165-185.
Pfitzner, K.E., et al., “The Synthesis of Nucleoside-5′ Aldehydes”, Journal of the American Chemical Society, (1963), vol. 85, p. 3027.
Maleczka, R.E., et al., “Total Synthesis of Proposed Amphidinolide A via a Highly Selective Ring-Closing Metathesis”, Organic Letters, (2002), vol. 4, No. 17, pp. 2841-2844.
Linclau, B., et al., “Efficient Desymmetrization of “Pseudo”-C2-Symmetric Substrates: Illustration in the Synthesis of a Disubstituted Butenolide from Arabitol”, Journal of Organic Chemistry, (2003), vol. 68, No. 5, pp. 1821-1826.
International Search report for Application No. PCT/EP2006/060246 mailed Jul. 26, 2006.
Solola Taofiq A
Tibotec Pharmaceuticals Ltd.
LandOfFree
Protease inhibitor precursor synthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protease inhibitor precursor synthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protease inhibitor precursor synthesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4266170